Auxilium merges with Canadian biotech in tax-inversion effort

Share this article:

Auxilium stated today it will merge with Canadian biotechnology company QLT. Under the agreement, QLT will now be known as “New Auxilium.” The new leadership team will include two current QLT directors, although the company stated that it “does not expect any material changes to its current US operations or employment as a result of this transaction.” QLT is based out of Vancouver, and as such the newly combined company will take advantage of Canada's lower corporate tax rate, in what the New York Times called “one of the smallest inversions in recent years.” Auxilium's new tax rate is believed to be in the mid-20% range, according to the NYT.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.